Squarepoint’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$358K Sell
12,102
-23,003
-66% -$680K ﹤0.01% 2080
2025
Q1
$1.05M Sell
35,105
-4,450
-11% -$133K ﹤0.01% 1480
2024
Q4
$1.13M Sell
39,555
-82,918
-68% -$2.38M ﹤0.01% 1454
2024
Q3
$4.73M Buy
122,473
+12,135
+11% +$469K 0.01% 771
2024
Q2
$3.55M Buy
110,338
+72,874
+195% +$2.35M 0.01% 811
2024
Q1
$1.45M Sell
37,464
-1,272
-3% -$49.4K ﹤0.01% 1178
2023
Q4
$1.19M Sell
38,736
-13,627
-26% -$419K ﹤0.01% 1275
2023
Q3
$1.17M Buy
52,363
+27,076
+107% +$605K ﹤0.01% 1226
2023
Q2
$543K Buy
+25,287
New +$543K ﹤0.01% 1560
2022
Q2
Sell
-36,997
Closed -$753K 2199
2022
Q1
$753K Buy
36,997
+22,108
+148% +$450K ﹤0.01% 1272
2021
Q4
$278K Buy
+14,889
New +$278K ﹤0.01% 1902
2021
Q3
Sell
-29,096
Closed -$688K 2313
2021
Q2
$688K Buy
29,096
+18,147
+166% +$429K ﹤0.01% 1419
2021
Q1
$259K Buy
+10,949
New +$259K ﹤0.01% 1989
2020
Q4
Sell
-10,944
Closed -$228K 2582
2020
Q3
$228K Sell
10,944
-7,317
-40% -$152K ﹤0.01% 1857
2020
Q2
$320K Sell
18,261
-15,537
-46% -$272K 0.01% 1532
2020
Q1
$552K Sell
33,798
-34,542
-51% -$564K 0.01% 979
2019
Q4
$1.41M Sell
68,340
-13,977
-17% -$288K 0.01% 1093
2019
Q3
$945K Buy
82,317
+4,843
+6% +$55.6K 0.01% 1243
2019
Q2
$1.02M Buy
77,474
+27,613
+55% +$363K 0.01% 1236
2019
Q1
$755K Buy
49,861
+31,725
+175% +$480K 0.01% 1236
2018
Q4
$311K Sell
18,136
-33,764
-65% -$579K ﹤0.01% 1476
2018
Q3
$765K Buy
51,900
+18,100
+54% +$267K 0.01% 1110
2018
Q2
$806K Buy
33,800
+17,092
+102% +$408K 0.01% 975
2018
Q1
$427K Sell
16,708
-9,387
-36% -$240K 0.01% 1146
2017
Q4
$482K Buy
+26,095
New +$482K 0.01% 1223